Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular approaches to chemo-radiotherapy.

B Marples1, O Greco, M C Joiner

  • 1Experimental Oncology, Gray Cancer Institute, PO Box 100, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, UK. marples@gci.ac.uk

European Journal of Cancer (Oxford, England : 1990)
|January 23, 2002
PubMed
Summary

New gene-directed enzyme prodrug therapy (GDEPT) systems utilize radiation or hypoxia-responsive promoters for targeted cancer treatment. These strategies enhance tumor specificity and cytotoxicity, overcoming limitations in current cancer gene therapy approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shaping a better future for children living with rare diseases: The pivotal role of paediatric nurses.

Journal of pediatric nursing·2025
Same author

Workplace violence in radiology: results of a systematic review.

Occupational medicine (Oxford, England)·2023
Same author

Effects of photobiomodulation and caffeine treatment on acute kidney injury in a hypoxic ischemic neonatal rat model.

Physiological reports·2023
Same author

Health care providers' weight management practices for adolescent obesity and alignment with clinical practice guidelines: a multi-centre, qualitative study.

BMC health services research·2020
Same author

Feasibility, user experiences, and preliminary effect of <i>Conversation Cards for Adolescents©</i> on collaborative goal-setting and behavior change: protocol for a pilot randomized controlled trial.

Pilot and feasibility studies·2020
Same author

End-user perspectives to inform policy and program decisions: a qualitative and quantitative content analysis of lifestyle treatment recommendations by adolescents with obesity.

BMC pediatrics·2019

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Radiotherapy faces challenges due to normal tissue toxicity and tumor radioresistance.
  • Cancer gene therapy offers potential but is limited by poor gene delivery and lack of tumor specificity.
  • Gene-directed enzyme prodrug therapy (GDEPT) aims to improve tumor targeting using specific promoters.

Purpose of the Study:

  • To develop and evaluate novel GDEPT systems controlled by radiation- or hypoxia-responsive promoters for enhanced cancer gene therapy.
  • To improve tumor specificity and therapeutic efficacy by precisely controlling gene expression within tumors.

Main Methods:

  • Designed synthetic radiation-responsive promoters based on Egr1 CArG elements for activation by clinically relevant radiation doses.
  • Utilized herpes simplex virus thymidine kinase (HSV-tk) gene with ganciclovir (GCV) prodrug for GDEPT.

Related Experiment Videos

  • Incorporated a Cre/loxP recombinase system and a fusion protein of HSV-tk with HSV protein vp22 to enhance GDEPT efficacy and bystander effects.
  • Developed hypoxia-responsive element (HRE)-containing promoters for GDEPT in hypoxic tumors.

    • Main Results:

    • The synthetic CArG promoters showed 2-3 fold activation at 3 Gy radiation in tumor cell lines.
    • GDEPT using CArG promoters and HSV-tk/GCV resulted in significantly greater cytotoxicity than radiation or GCV alone.
    • The molecular switch system and HSV-tk/vp22 fusion protein notably increased GDEPT bystander cell killing.
    • Hypoxia-responsive promoters were also described for GDEPT applications.

    Conclusions:

    • Targeted gene expression via selective promoters is crucial for improving specificity and efficacy in cancer gene therapy.
    • Radiation- and hypoxia-responsive GDEPT systems offer promising strategies to overcome current limitations in cancer treatment.
    • These advancements hold potential for more effective and targeted cancer therapies with reduced normal tissue damage.